Select Page

Israeli-founded AI biotech Immunai expands AstraZeneca cancer collaboration

by | May 7, 2026 | Innovation, JPost Tech | 0 comments

The expanded agreement extends and broadens the companies’ multi-year collaboration in oncology through 2027, according to the statement. | Read More in JPost.com – Tech | The Jerusalem Post